Abstract

Problem statement: Citrullus Colocynthis (L.) Schrab (cucurbitaceae family) (Handal) is a fruit commonly known as bitter apple or bitter cucu mber. Traditionally , Citrullus colocynthis has been used for the treatment of diabetes. In particular, the acute effect and rout of administration of etha nol extract of the seedless pulp in vivo remains untested. We investigated the effect of di fferent routs of administration and their hypoglycemic and insulinot ropic effects of ethanol/water (20/80 V/V) extract of the dried seedless pulp of Citrullus colocynthis (L.) Schrab on normal and alloxan-induced diabetic rats. Approach: Rats were divided into two groups, normal and diab etic rats. Non-diabetic rats were fasted for 18 h before the beginning of the experim ental procedure. About 250 �L of normal saline (i.e., vehicle) was administered to control groups either i.p. (Group I) or orally (Group III) using modified feeding canula. As 250 �L pulp extract was administered i.p. (Group II) or orally (Group IV). Five min, after the administration of the extract o r vehicle, an Intraperitoneal Glucose Tolerance Tes t (IPGTT) was conducted (1.5 g glucose/kg) on groups I, II, III and IV, but not Groups V or VI. Alloxan-induced diabetic rats were fasted for 6 h b efore the beginning of the experimental procedure. They were divided into control (Group V) and treate d groups (Group VI), each of 6 rats. As 250 �L of the extract (equivalent to 300 mg kg -1 ) was administered orally to alloxan treated-group, while 250 �L of the vehicle was administrated orally to the anim als of control group. Serum samples were collected at 0, 1, 2, 3, 4 and 6 h following the treatment an d were used for glucose and insulin determination. Results: Oral, but not intraperitonial (i.p.) administratio n of ethanol extract (300 mg kg -1 ) resulted in acute, significant (p <0.05) and time-dependent changes in rat serum gluco se and insulin levels in both normal and alloxan-induced diabetic rats. In extrac t-treated alloxan-free rats, a maximum of 32.9% reduction in serum glucose levels was observed foll owing Intraperitonial Glucose Tolerance Test (IPGTT) using glucose-oxidase assay. A maximum reciprocal increase of 59.5% in serum insulin levels following IPGTT was determined by ELISA. Further, in alloxan/ethanol extract-treated group, a maximum of 31% reduction in serum glucose levels as well as 370.2% increase in serum insulin levels following IPGTT were observed. Conclusion: These results demonstrated that oral administratio n of the ethanol extract of the dried seedless pulp of Citrullus colocynthis had normo-hypoglycemic (i.e., in normal rats), antihyperglycemic as well as insulino tropic actions in alloxan-induced diabetic rats.

Highlights

  • Diabetes Mellitus (DM) is a common endocrine disease, possibly the world’s fastest growing metabolic disease

  • In the presence of Intraperitoneal Glucose Tolerance Test (IPGTT), 500 mg kg−1 reduced serum glucose levels from (257±5.6-155±3.4), an effect similar to that observed at the dose of 300 mg kg−1 without IPGTT, Fig. 2: Experimental procedure in alloxan-induced diabetic rats while 600 mg kg−1 was found lethal

  • A preliminary comparison of the individual effect of the peel, pulp or seeds portions of Citrullus colocynthis on blood glucose levels showed that only the pulp but not the peel or the seeds exhibited marked hypoglycemic effect on serum glucose levels

Read more

Summary

Introduction

Diabetes Mellitus (DM) is a common endocrine disease, possibly the world’s fastest growing metabolic disease. DM can be defined as a group of metabolic diseases characterized by chronic hyperglycemia, resulting from defects in insulin secretion, insulin action or both, causing impaired carbohydrate, lipid and. & Biotech., 5 (3): 118-125, 2009 protein metabolism and an increased risk of cardiovascular diseases[1]. Knowledge of its heterogeneous phenotypes is on the rise[2]. Diabetes is recognized as one of the leading causes of morbidity and mortality in the world; about 2.5-7% of the world's population are diagnosed with diabetes mellitus[3]. Despite of the significant effect of anti-hyperglycemic drugs and insulin sensitizers, there remains side effects that necessitate finding other alternatives

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call